Transform Cancer Care with Precision Medicine
AGTC Genomics Cancer Solutions use comprehensive tumor profiling to analyze both DNA and RNA with Next Generation Sequencing (NGS) technologies, revealing a more complete molecular blueprint to guide precise and personalized treatment decisions.
With the promise of precision medicine becoming a reality, molecular profiling has become the standard of care for many cancer types—and is required for certain therapies. More than ever, oncologists and patients need a trusted tumor profiling partner to deliver reliable, high-quality molecular information that enables more precise and personalized treatment decisions.
AGTC Cancer Genomics Solutions help oncologists and patients:
• navigate among therapies with potential benefits;
• identify therapies that may not have been considered;
• determine drugs with a potential lack of benefit (avoiding unnecessary toxicities and costs); and
• match patients to clinical trials.
Change how your cancer is treated
AGTC Genomics can provide your doctor with cutting-edge information to drive, and potentially alter, treatment decisions to change the course of your disease through our personalized cancer genetic testing.
We’re part of your team
AGTC Genomics’ best-in-class molecular profiling, combined with proprietary database and artificial intelligence, gives you the best information possible to make treatment decisions for your patients.
-
Proven Technology Validated Internationally
Our services are based on proven technology used internationally, validated through extensive research, and complied to international guidelines. -
Supported by Healthcare Professional
Supported by a team of oncologists, pathologists, hematologists, molecular geneticists, bioinformaticians, and PhD scientists dedicated to improving the lives of patients. -
Local Testing with High Data Security
End-to-end services conducted in our lab in Malaysia, avoid the risk of sample missing when sending it to overseas for testing.
Personalized cancer care with molecular profiling
Knowing what cancer looks like at the molecular level can lead to better treatment options for patients. Cancer tests and treatments have advanced dramatically over the years, and it is increasingly important to understand the molecular features of a cancer when the diagnosis is made so oncologists can create a personalized treatment plan. Regardless of where a tumor is located, its molecular composition tells doctors a lot about how the cancer may behave and what treatments may be most effective.
CancerRiskDx™
Hereditary Cancer Screening
For those with a cancer-prone family history
-
300+ cancer-causing mutations
-
125+ types of the most common hereditary cancers
-
Colorectal, breast, ovarian, prostate, lung, pancreatic, leukemia and more
Sample types
Saliva, Blood or Buccal Swab
CancerScreenDx™
Multi-Cancer Early Detection
For healthy individuals seeking cancer screening
-
160+ cancer causing mutations in blood
-
85+ types of the most common cancers
-
Detect cancer at an early stage when it is most treatable
Sample types
Blood
PreciseDx™
Multimodal Comprehensive Gene Profiling (CGP)
For cancer patients seeking personalized treatment recommendations
-
520+ actionable DNA mutations in tumor tissues
-
Identifying SNVs, CNVs, Indels, gene fusion, MSI, TMB, HRD
-
Detect genetic mutations for targeted therapy or immunotherapy selection
Sample types
Tumor Tissues, FFPE
LiquidDx™
Circulating Tumour DNA (ctDNA) Liquid Biopsy
For metastatic cancer patients seeking personalized treatment recommendations
-
520+ cancer-specific mutations in the blood
-
Non-invasive test that does not use radiation
-
Guide selection of targeted therapy or immunotherapy for metastatic cancers
Sample types
Blood
